{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "Determinar los factores asociados a la supervivencia en el primer a\u00f1o de vida en neonatos con cardiopat\u00eda cong\u00e9nita severa atendidos en un hospital nacional de Per\u00fa.",
        "Se estudiaron 160 ni\u00f1os nacidos entre el 2012 y 2015 con diagn\u00f3stico de alguna cardiopat\u00eda cong\u00e9nita severa que ingresaron al Servicio de Neonatolog\u00eda del Hospital Nacional Edgardo Rebagliati Martins del Seguro Social del Per\u00fa. En el an\u00e1lisis de supervivencia se utiliz\u00f3 el m\u00e9todo de Kaplan-Meier y la prueba Log-Rank. Se realizaron an\u00e1lisis crudos y ajustados mediante modelos de regresi\u00f3n de Cox.",
        "El 52,5% de los pacientes fueron de sexo masculino y la cardiopat\u00eda cong\u00e9nita severa m\u00e1s frecuente fue la atresia pulmonar (26,3%). El 33,7% de los pacientes fallecieron, siendo la supervivencia al a\u00f1o del 66,3% (IC95% 58,4-73,0). El diagn\u00f3stico prenatal mejor\u00f3 la supervivencia (HRa 0,54, IC95%: 0,30-0,98) mientras que las cardiopat\u00edas de tipo cian\u00f3ticas (HRa 2,93, IC95%: 1,36-6,34) y la presencia de otra anomal\u00eda cong\u00e9nita (HRa 3,28, IC95%: 1,79-6,01) la disminuyeron, estos factores fueron tambi\u00e9n significativos en un segundo modelo estratificado por tratamiento quir\u00fargico con excepci\u00f3n del modelo estratificado por complicaciones donde un diagn\u00f3stico prenatal dej\u00f3 de ser significativo.",
        "El diagn\u00f3stico prenatal incrementa la supervivencia ante una cardiopat\u00eda cong\u00e9nita severa y permitir\u00eda un tratamiento quir\u00fargico oportuno; sin embargo, se debe considerar que las cardiopat\u00edas de tipo cian\u00f3ticas y la presencia de otras anomal\u00edas cong\u00e9nitas extracard\u00edacas disminuyen la supervivencia si se realiza una intervenci\u00f3n quir\u00fargica o se presentan complicaciones."
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "31800935",
  "DateCompleted": {
    "Year": "2020",
    "Month": "05",
    "Day": "20"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "05",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2019",
        "Month": "12",
        "Day": "02"
      }
    ],
    "Language": [
      "spa"
    ],
    "ELocationID": [
      "10.17843/rpmesp.2019.363.4166"
    ],
    "Journal": {
      "ISSN": "1726-4642",
      "JournalIssue": {
        "Volume": "36",
        "Issue": "3",
        "PubDate": {
          "Year": "2019",
          "Season": "Jul-Sep"
        }
      },
      "Title": "Revista peruana de medicina experimental y salud publica",
      "ISOAbbreviation": "Rev Peru Med Exp Salud Publica"
    },
    "ArticleTitle": "[Factors associated with survival at one year of life in neonates with severe congenital cardiopathy in A National Hospital in Peru].",
    "Pagination": {
      "StartPage": "433",
      "EndPage": "441",
      "MedlinePgn": "433-441"
    },
    "Abstract": {
      "AbstractText": [
        "To determine factors associated with survival in the first year of life in neonates with severe congenital heart disease treated in a national hospital in Peru.",
        "160 children born between 2012 and 2015 with a diagnosis of severe congenital cardiopathy were studied and admitted to the Neonatology Service of the Edgardo Rebagliati Martins National Hospital of the Peruvian Social Security. The Kaplan-Meier method and the Log-Rank test were used in the survival analysis. Crude and adjusted analyses were performed using Cox regression models.",
        "Fifty-two, point 5 percent (52.5%) of patients were male and the most frequent severe congenital cardiopathy was pulmonary atresia (26.3%). Thirty-three, point seven percent (33.7%) of patients died, with a 66.3% (IC95% 58.4-73.0) one-year survival. Prenatal diagnosis improved survival (HRa 0.54, 95% CI 0.30-0.98) while cyanotic cardiopathies (HRa 2.93, 95% CI 1.36-6.34) and the presence of another congenital anomaly (HRa 3.28, 95% CI 1.79-6.01) decreased it; these factors were also significant in a second model stratified by surgical treatment with the exception of the stratified model by complications where a prenatal diagnosis ceased to be significant.",
        "Prenatal diagnosis increases survival from severe congenital heart disease. However, cyanotic heart diseases and other congenital anomalies, which decrease this chance, should be considered, if surgery is performed or complications occur."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Facultad de Medicina, Universidad Nacional San Luis Gonzaga. Ica, Per\u00fa."
          }
        ],
        "LastName": "Torres-Romucho",
        "ForeName": "Camilo E",
        "Initials": "CE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Facultad de Medicina, Universidad Nacional San Luis Gonzaga. Ica, Per\u00fa."
          },
          {
            "Identifier": [],
            "Affiliation": "Hospital Nacional Alberto Sabogal Sologuren. Lima, Per\u00fa."
          }
        ],
        "LastName": "Uriondo-Ore",
        "ForeName": "Victor G",
        "Initials": "VG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Facultad de Medicina, Universidad Nacional San Luis Gonzaga. Ica, Per\u00fa."
          },
          {
            "Identifier": [],
            "Affiliation": "Hospital Regional de Ica. Ica, Per\u00fa."
          }
        ],
        "LastName": "Ramirez-Palomino",
        "ForeName": "Alberto J",
        "Initials": "AJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Oficina General de Informaci\u00f3n y Sistemas, Instituto Nacional de Salud. Lima, Per\u00fa."
          }
        ],
        "LastName": "Arroyo-Hern\u00e1ndez",
        "ForeName": "Hugo",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidad de Cardiopediatr\u00eda, Hospital Nacional Edgardo Rebagliati Martins. Lima, Per\u00fa."
          },
          {
            "Identifier": [],
            "Affiliation": "Universidad Ricardo Palma. Lima, Per\u00fa."
          }
        ],
        "LastName": "Loo-Valverde",
        "ForeName": "Maria",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Servicio de Gen\u00e9tica, Hospital Nacional Edgardo Rebagliati Martins. Lima, Per\u00fa."
          }
        ],
        "LastName": "Protzel-Pinedo",
        "ForeName": "Ana",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Servicio de Gen\u00e9tica, Hospital Nacional Edgardo Rebagliati Martins. Lima, Per\u00fa."
          },
          {
            "Identifier": [],
            "Affiliation": "Estudio Colaborativo Latinoamericano de Malformaciones Cong\u00e9nitas (ECLAMC)."
          }
        ],
        "LastName": "Due\u00f1as-Roque",
        "ForeName": "Milagros",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Observational Study"
    ],
    "VernacularTitle": "Factores asociados a la supervivencia al a\u00f1o de vida en neonatos con cardiopat\u00eda cong\u00e9nita severa en un Hospital Nacional de Per\u00fa."
  },
  "MedlineJournalInfo": {
    "Country": "Peru",
    "MedlineTA": "Rev Peru Med Exp Salud Publica",
    "NlmUniqueID": "101227566",
    "ISSNLinking": "1726-4634"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Cohort Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "mortality",
        "therapy"
      ],
      "DescriptorName": "Heart Defects, Congenital"
    },
    {
      "QualifierName": [
        "congenital",
        "mortality",
        "therapy"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hospitals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant, Newborn"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Peru"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Retrospective Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Severity of Illness Index"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Survival Analysis"
    }
  ]
}